Ovarian Cancer | Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian Cancer

Research To Practice | Oncology Videos · Dec 21, 2022 · 49m

Featuring perspectives from Dr Thomas Herzog, including the following topics:

Impact of PARP inhibitors (PARPi) on the care of patients with ovarian cancer (0:00)

Clarifying the recent withdrawal of PARPi for treatment of recurrent or refractory ovarian cancer (4:13)

Sequential use of PARPi for patients with advanced ovarian cancer (16:56)

Case: Woman in her late 60s with BRCA wild type ovarian cancer (20:06)

Case: Woman in her early 50s with somatic BRCA-positive high-grade serous ovarian cancer (39:22)

Case: Woman in her mid 60s with BRCA wild type and homologous recombination-deficient…